TapewireFind a company

person · Reporting owner

Joseph Wetteny

Disclosed activity across 3 companies

Tapewire entity
30520
SEC CIK
0001285781

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ASHLAND INC.ASH · Entity 4139DirectorJanuary 23, 2024January 25, 2024
Catalent, Inc.CTLT · Entity 16279SVP & Chief Financial OfficerFebruary 16, 2021February 18, 2021
Zoetis Inc.ZTS · Entity 679Chief Financial OfficerJuly 10, 2026July 14, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ASHLAND INC.

Report date January 23, 2024 · Filed January 25, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect5,834 Reported balance After 2024-01-23 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2024-01-23 · Grant · Acquired 1,897 · Balance 5,834

F1: Each Restricted Stock Unit (RSU) represents a right to receive one (1) share of Ashland Common Stock.

F2: Grant of stock-settled Restricted Stock Units granted under the Ashland Inc. Omnibus Incentive Plan. The Restricted Stock Units are deferred at the election of the Reporting Person under the Ashland Inc. Deferred Compensation Plan for Non-Employee Directors until retirement from service as a director. The Restricted Stock Units will vest one year after the grant date. One (1) Restricted Stock Unit in the Ashland Inc. Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.

F3: Balance includes additional Restricted Stock Units acquired in lieu of cash dividends.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit (RSU) represents a right to receive one (1) share of Ashland Common Stock.

F2: Grant of stock-settled Restricted Stock Units granted under the Ashland Inc. Omnibus Incentive Plan. The Restricted Stock Units are deferred at the election of the Reporting Person under the Ashland Inc. Deferred Compensation Plan for Non-Employee Directors until retirement from service as a director. The Restricted Stock Units will vest one year after the grant date. One (1) Restricted Stock Unit in the Ashland Inc. Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.

F3: Balance includes additional Restricted Stock Units acquired in lieu of cash dividends.

Catalent, Inc.

Report date February 16, 2021 · Filed February 18, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect49,823 Last balance in matching sequence After 2021-02-16 transaction · row 6 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
6 source rows

Row 1 · 2021-02-16 · Exercise / conversion · Acquired 1,076 · Balance 50,899

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.

F2: Includes restricted stock units.

Row 2 · 2021-02-16 · Exercise / conversion · Acquired 3,924 · Balance 54,823

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.

F2: Includes restricted stock units.

Row 3 · 2021-02-16 · Sale · Disposed 1,799 · Balance 53,024

F3: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1.

F4: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $122.46 to $123.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: Includes restricted stock units.

Row 4 · 2021-02-16 · Sale · Disposed 1,200 · Balance 51,824

F3: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1.

F5: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $123.46 to $124.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: Includes restricted stock units.

Row 5 · 2021-02-16 · Sale · Disposed 1,001 · Balance 50,823

F3: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1.

F6: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $125.82 to $126.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: Includes restricted stock units.

Row 6 · 2021-02-16 · Sale · Disposed 1,000 · Balance 49,823

F3: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1.

F7: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $126.87 to $127.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: Includes restricted stock units.

Options to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $43.88 · Expires 2028-07-23Direct17,631 Reported balance After 2021-02-16 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2021-02-16 · Exercise / conversion · Disposed 1,076 · Balance 17,631

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.

F8: The options vest and become exercisable in four equal annual installments beginning on July 23, 2019.

Options to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $54.94 · Expires 2029-07-22Direct11,773 Reported balance After 2021-02-16 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2021-02-16 · Exercise / conversion · Disposed 3,924 · Balance 11,773

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.

F9: The options vest and become exercisable in four equal annual installments beginning on July 22, 2020.

Filing footnotes · ownership attribution and instrument terms

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.

F2: Includes restricted stock units.

F3: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1.

F4: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $122.46 to $123.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $123.46 to $124.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $125.82 to $126.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $126.87 to $127.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: The options vest and become exercisable in four equal annual installments beginning on July 23, 2019.

F9: The options vest and become exercisable in four equal annual installments beginning on July 22, 2020.

Zoetis Inc.

Report date July 10, 2026 · Filed July 14, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom Stock UnitSEC Table II · derivative / convertible securityDirect10,155.3554 Reported balance After 2026-07-10 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-07-10 · Grant · Acquired 363.0526 · Balance 10,155.3554

F1: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

Filing footnotes · ownership attribution and instrument terms

F1: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
April 06, 2023 Filed Apr 10, 2023 20:31 UTC Zoetis Inc. ZTS · Entity 679 GrantPhantom Stock Unit · Derivative 302.4176 $53.59 $16,206.56
Disclosure

SEC source: 0001555280-23-000132 · wf-form4_168115869364208.xml · derivative · entry 1

Joseph Wetteny · CIK 0001285781 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,747.0382

Underlying: Common Stock · 95.9309 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 21:14 UTC Zoetis Inc. ZTS · Entity 679 GrantPhantom Stock Unit · Derivative 491.9788 $52.84 $25,996.16
Disclosure

SEC source: 0001555280-23-000120 · wf-form4_168064286566092.xml · derivative · entry 1

Joseph Wetteny · CIK 0001285781 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,444.6206

Underlying: Common Stock · 156.1894 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
February 08, 2023 Filed Feb 10, 2023 23:27 UTC Zoetis Inc. ZTS · Entity 679 GrantStock Option · Derivative 15,208 $0.00 Strike: $162.07 $0.00
Disclosure

SEC source: 0001555280-23-000056 · wf-form4_167607164008722.xml · derivative · entry 3

Joseph Wetteny · CIK 0001285781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,208

Underlying: Common Stock · 15,208 shares

Expires not disclosed

F8 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.

F9 · derivative.exercise_date: One-third of each option will vest on the first, second and third anniversaries of the date of grant.

F10 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

Read SEC document
February 08, 2023 Filed Feb 10, 2023 23:27 UTC Zoetis Inc. ZTS · Entity 679 GrantRestricted Stock Unit · Derivative 4,087 $0.00 $0.00
Disclosure

SEC source: 0001555280-23-000056 · wf-form4_167607164008722.xml · derivative · entry 1

Joseph Wetteny · CIK 0001285781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,087

Underlying: Common Stock · 4,087 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). One-third of the RSUs vest and are settled in shares of Zoetis common stock on each of the first, second and third anniversaries of the date of grant, respectively, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document
January 24, 2023 Filed Jan 26, 2023 22:36 UTC ASHLAND INC. ASH · Entity 4139 GrantRestricted Stock Units · Derivative 1,365 $109.85 $149,945.25
Disclosure

SEC source: 0001127602-23-002342 · form4.xml · derivative · entry 1

Joseph Wetteny · CIK 0001285781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,872

Underlying: Common Stock · 1,365 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock.

F2 · derivative.exercise_date: Grant of stock settled Restricted Stock Units granted under Ashland Omnibus Incentive Plan and deferred at the election of the reporting person under Ashland Inc. Independent Director Deferred Compensation Program dated November 17, 2022 until retirement from service as a director. The Restricted Stock Units will vest one year after date of grant. One (1) Restricted Stock Units in the Ashland Inc. Independent Director Deferred Compensation Program is the equivalent of one (1) share of Ashland Common Stock.

F2 · derivative.expiration_date: Grant of stock settled Restricted Stock Units granted under Ashland Omnibus Incentive Plan and deferred at the election of the reporting person under Ashland Inc. Independent Director Deferred Compensation Program dated November 17, 2022 until retirement from service as a director. The Restricted Stock Units will vest one year after date of grant. One (1) Restricted Stock Units in the Ashland Inc. Independent Director Deferred Compensation Program is the equivalent of one (1) share of Ashland Common Stock.

F3 · balance_after: Balance includes 8 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2022, 8 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2022, 8 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2022 and 7 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2022,

Read SEC document
January 13, 2023 Filed Jan 18, 2023 21:30 UTC Zoetis Inc. ZTS · Entity 679 GrantPhantom Stock Unit · Derivative 158.3097 $51.02 $8,076.96
Disclosure

SEC source: 0001555280-23-000018 · wf-form4_167407743295645.xml · derivative · entry 1

Joseph Wetteny · CIK 0001285781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 952.6418

Underlying: Common Stock · 302.037 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:36 UTC Zoetis Inc. ZTS · Entity 679 GrantPhantom Stock Unit · Derivative 201.521 $46.76 $9,423.12
Disclosure

SEC source: 0001555280-22-000250 · wf-form4_166552053733662.xml · derivative · entry 1

Joseph Wetteny · CIK 0001285781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 794.3321

Underlying: Common Stock · 252.0389 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 15, 2022 Filed Jul 19, 2022 21:17 UTC Zoetis Inc. ZTS · Entity 679 GrantPhantom Stock Unit · Derivative 172.0175 $54.78 $9,423.12
Disclosure

SEC source: 0001555280-22-000214 · wf-form4_165826541760213.xml · derivative · entry 1

Joseph Wetteny · CIK 0001285781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 592.8111

Underlying: Common Stock · 186.0559 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
April 08, 2022 Filed Apr 13, 2022 00:09 UTC Zoetis Inc. ZTS · Entity 679 GrantPhantom Stock Unit · Derivative 263.7277 $62.20 $16,403.86
Disclosure

SEC source: 0001555280-22-000157 · wf-form4_164980852223077.xml · derivative · entry 1

Joseph Wetteny · CIK 0001285781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 420.7936

Underlying: Common Stock · 130.8079 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
March 30, 2022 Filed Apr 1, 2022 22:08 UTC Zoetis Inc. ZTS · Entity 679 GrantPhantom Stock Unit · Derivative 91.4276 $59.61 $5,450.00
Disclosure

SEC source: 0001555280-22-000138 · wf-form4_164885088081475.xml · derivative · entry 1

Joseph Wetteny · CIK 0001285781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157.0659

Underlying: Common Stock · 28.4863 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
February 08, 2022 Filed Feb 10, 2022 23:37 UTC Zoetis Inc. ZTS · Entity 679 GrantStock Option · Derivative 11,243 $0.00 $0.00
Disclosure

SEC source: 0001555280-22-000054 · wf-form4_164453620455599.xml · derivative · entry 2

Joseph Wetteny · CIK 0001285781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,243

Underlying: Common Stock · 11,243 shares

Expires not disclosed

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 11,243 options granted February 8, 2022 at an exercise price of $201.30 per option.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 11,243 options granted February 8, 2022 at an exercise price of $201.30 per option.

Read SEC document
February 08, 2022 Filed Feb 10, 2022 23:37 UTC Zoetis Inc. ZTS · Entity 679 GrantRestricted Stock Unit · Derivative 2,856 $0.00 $0.00
Disclosure

SEC source: 0001555280-22-000054 · wf-form4_164453620455599.xml · derivative · entry 1

Joseph Wetteny · CIK 0001285781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,332.3751

Underlying: Common Stock · 2,856 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 27,476.3751 RSUs will vest on June 30, 2024; and 2,856 RSUs will vest on February 8, 2025.

Read SEC document
January 24, 2022 Filed Jan 25, 2022 22:00 UTC ASHLAND INC. ASH · Entity 4139 GrantRestricted Stock Units · Derivative 1,139 $96.61 $110,038.79
Disclosure

SEC source: 0001127602-22-002072 · form4.xml · derivative · entry 1

Joseph Wetteny · CIK 0001285781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,474

Underlying: Common Stock · 1,139 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a right to receive one (1) share of Ashland Common Stock.

F2 · derivative.exercise_date: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.)

F2 · derivative.expiration_date: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.)

F3 · balance_after: Balance includes 4 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2021; 4 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2021; 4 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2021; 4 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2021.

Read SEC document
January 14, 2022 Filed Jan 19, 2022 22:10 UTC Zoetis Inc. ZTS · Entity 679 GrantPhantom Stock Unit · Derivative 65.6383 $63.87 $4,192.32
Disclosure

SEC source: 0001555280-22-000019 · wf-form4_164263020650620.xml · derivative · entry 1

Joseph Wetteny · CIK 0001285781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65.6383

Underlying: Common Stock · 20.3333 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
June 30, 2021 Filed Jul 2, 2021 20:28 UTC Zoetis Inc. ZTS · Entity 679 GrantRestricted Stock Unit · Derivative 7,512 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000255 · wf-form4_162525769654890.xml · derivative · entry 2

Joseph Wetteny · CIK 0001285781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,366

Underlying: Common Stock · 7,512 shares

Expires not disclosed

F5 · security: Represents vested restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. These restricted stock units are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to earlier settlement upon certain specific events. Dividend equivalent units are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to earlier settlement upon certain specific events.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F6 · derivative.exercise_date: Each vested restricted stock unit will be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to earlier settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: Represents vested restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. These restricted stock units are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to earlier settlement upon certain specific events. Dividend equivalent units are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to earlier settlement upon certain specific events.

Read SEC document
June 30, 2021 Filed Jul 2, 2021 20:28 UTC Zoetis Inc. ZTS · Entity 679 GrantRestricted Stock Unit · Derivative 19,854 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000255 · wf-form4_162525769654890.xml · derivative · entry 1

Joseph Wetteny · CIK 0001285781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,854

Underlying: Common Stock · 19,854 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. These restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each restricted stock unit will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F1 · balance_after: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. These restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 14:56 UTC Catalent, Inc. CTLT · Entity 16279 Exercise / conversionOptions to purchase Common Stock · Derivative 3,924 $0.00 Strike: $54.94 $0.00
Disclosure

SEC source: 0001596783-21-000042 · wf-form4_161366015633591.xml · derivative · entry 8

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,773

Underlying: Common Stock · 3,924 shares

Expires 2029-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.

F9 · derivative.exercise_date: The options vest and become exercisable in four equal annual installments beginning on July 22, 2020.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 14:56 UTC Catalent, Inc. CTLT · Entity 16279 Exercise / conversionOptions to purchase Common Stock · Derivative 1,076 $0.00 Strike: $43.88 $0.00
Disclosure

SEC source: 0001596783-21-000042 · wf-form4_161366015633591.xml · derivative · entry 7

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,631

Underlying: Common Stock · 1,076 shares

Expires 2028-07-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.

F8 · derivative.exercise_date: The options vest and become exercisable in four equal annual installments beginning on July 23, 2019.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 14:56 UTC Catalent, Inc. CTLT · Entity 16279 SaleCommon Stock 1,000 $127.00 $127,000.00
Disclosure

SEC source: 0001596783-21-000042 · wf-form4_161366015633591.xml · nonDerivative · entry 6

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,823

F3 · kind: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1.

F7 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $126.87 to $127.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes restricted stock units.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 14:56 UTC Catalent, Inc. CTLT · Entity 16279 SaleCommon Stock 1,001 $126.13 $126,256.13
Disclosure

SEC source: 0001596783-21-000042 · wf-form4_161366015633591.xml · nonDerivative · entry 5

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,823

F3 · kind: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1.

F6 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $125.82 to $126.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes restricted stock units.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 14:56 UTC Catalent, Inc. CTLT · Entity 16279 SaleCommon Stock 1,200 $123.73 $148,476.00
Disclosure

SEC source: 0001596783-21-000042 · wf-form4_161366015633591.xml · nonDerivative · entry 4

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,824

F3 · kind: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1.

F5 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $123.46 to $124.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes restricted stock units.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 14:56 UTC Catalent, Inc. CTLT · Entity 16279 SaleCommon Stock 1,799 $122.82 $220,953.18
Disclosure

SEC source: 0001596783-21-000042 · wf-form4_161366015633591.xml · nonDerivative · entry 3

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,024

F3 · kind: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1.

F4 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $122.46 to $123.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes restricted stock units.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 14:56 UTC Catalent, Inc. CTLT · Entity 16279 Exercise / conversionCommon Stock 3,924 $54.94 $215,584.56
Disclosure

SEC source: 0001596783-21-000042 · wf-form4_161366015633591.xml · nonDerivative · entry 2

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,823

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.

F2 · balance_after: Includes restricted stock units.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 14:56 UTC Catalent, Inc. CTLT · Entity 16279 Exercise / conversionCommon Stock 1,076 $43.88 $47,214.88
Disclosure

SEC source: 0001596783-21-000042 · wf-form4_161366015633591.xml · nonDerivative · entry 1

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,899

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.

F2 · balance_after: Includes restricted stock units.

Read SEC document
February 08, 2021 Filed Feb 10, 2021 14:05 UTC Catalent, Inc. CTLT · Entity 16279 SaleCommon Stock 4,604 $113.73 $523,612.92
Disclosure

SEC source: 0001596783-21-000040 · wf-form4_161296589334844.xml · nonDerivative · entry 1

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,823

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to cover tax withholding obligations in connection with the vesting of restricted stock received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer.

F2 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $113.63 to $113.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes restricted stock units.

Read SEC document
January 26, 2021 Filed Jan 28, 2021 22:16 UTC ASHLAND INC. ASH · Entity 4139 GrantRestricted Stock Units · Derivative 1,319 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-002834 · form4.xml · derivative · entry 1

Joseph Wetteny · CIK 0001285781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,319

Underlying: Common Stock · 1,319 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a right to receive one (1) share of Ashland Common Stock.

F2 · derivative.exercise_date: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.)

F2 · derivative.expiration_date: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.)

Read SEC document
January 04, 2021 Filed Jan 6, 2021 02:46 UTC Catalent, Inc. CTLT · Entity 16279 SaleCommon Stock 172 $104.42 $17,960.24
Disclosure

SEC source: 0001596783-21-000018 · wf-form4_160990115198860.xml · nonDerivative · entry 1

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,427

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer.

F2 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $104.27 to $104.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes restricted stock units.

Read SEC document
August 27, 2020 Filed Aug 31, 2020 21:24 UTC Catalent, Inc. CTLT · Entity 16279 Tax withholdingCommon Stock 179 $87.71 $15,700.09
Disclosure

SEC source: 0001596783-20-000172 · wf-form4_159890903274377.xml · nonDerivative · entry 4

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,599

F2 · balance_after: Includes restricted stock units.

Read SEC document
August 27, 2020 Filed Aug 31, 2020 21:24 UTC Catalent, Inc. CTLT · Entity 16279 GrantCommon Stock 363 $0.00 $0.00
Disclosure

SEC source: 0001596783-20-000172 · wf-form4_159890903274377.xml · nonDerivative · entry 3

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,778

F3 · kind: Shares received by the reporting person under the issuer's long-term incentive plan in respect of the fiscal 2017-19 performance period that correct the original vested amount received on August 22, 2019.

F2 · balance_after: Includes restricted stock units.

Read SEC document
August 27, 2020 Filed Aug 31, 2020 21:24 UTC Catalent, Inc. CTLT · Entity 16279 Tax withholdingCommon Stock 3,301 $87.71 $289,530.71
Disclosure

SEC source: 0001596783-20-000172 · wf-form4_159890903274377.xml · nonDerivative · entry 2

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,415

F2 · balance_after: Includes restricted stock units.

Read SEC document
August 27, 2020 Filed Aug 31, 2020 21:24 UTC Catalent, Inc. CTLT · Entity 16279 GrantCommon Stock 9,544 $0.00 $0.00
Disclosure

SEC source: 0001596783-20-000172 · wf-form4_159890903274377.xml · nonDerivative · entry 1

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,716

F1 · kind: Received upon the achievement of the fiscal 2018-20 performance-based vesting criteria set forth in certain incentive compensation held by the reporting person under the issuer's long-term incentive plan.

F2 · balance_after: Includes restricted stock units.

Read SEC document
July 30, 2020 Filed Aug 3, 2020 16:01 UTC Catalent, Inc. CTLT · Entity 16279 GrantOptions to purchase Common Stock · Derivative 11,700 $0.00 Strike: $88.10 $0.00
Disclosure

SEC source: 0001596783-20-000117 · wf-form4_159647049735556.xml · derivative · entry 2

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,700

Underlying: Common Stock · 11,700 shares

Expires 2030-07-30

F3 · shares: Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan.

F4 · derivative.exercise_date: The options vest and become exercisable in four equal annual installments beginning on July 30, 2021.

Read SEC document
July 30, 2020 Filed Aug 3, 2020 16:01 UTC Catalent, Inc. CTLT · Entity 16279 GrantCommon Stock 2,157 $0.00 $0.00
Disclosure

SEC source: 0001596783-20-000117 · wf-form4_159647049735556.xml · nonDerivative · entry 1

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,172

F1 · shares: Restricted stock units (RSUs) received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur three (3) years from the date of award.

F2 · balance_after: Includes restricted stock units.

Read SEC document
July 24, 2020 Filed Jul 28, 2020 12:11 UTC Catalent, Inc. CTLT · Entity 16279 Tax withholdingCommon Stock 761 $81.64 $62,128.04
Disclosure

SEC source: 0001596783-20-000081 · wf-form4_159593828162784.xml · nonDerivative · entry 1

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,015

F1 · balance_after: Includes restricted stock units.

Read SEC document
April 09, 2020 Filed Apr 13, 2020 16:20 UTC Catalent, Inc. CTLT · Entity 16279 GrantCommon Stock 349 $56.46 $19,704.54
Disclosure

SEC source: 0001596783-20-000041 · wf-form4_158679483988706.xml · nonDerivative · entry 1

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,776

F1 · shares: Restricted stock units (RSUs) received in lieu of reporting person's receipt of certain other compensation. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on December 31, 2020.

F2 · balance_after: Includes restricted stock units.

Read SEC document
August 22, 2019 Filed Aug 26, 2019 19:48 UTC Catalent, Inc. CTLT · Entity 16279 Tax withholdingCommon Stock 4,176 $55.24 $230,682.24
Disclosure

SEC source: 0001596783-19-000160 · wf-form4_156684891234566.xml · nonDerivative · entry 2

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,427

F2 · balance_after: Includes restricted stock units.

Read SEC document
August 22, 2019 Filed Aug 26, 2019 19:48 UTC Catalent, Inc. CTLT · Entity 16279 GrantCommon Stock 11,261 $0.00 $0.00
Disclosure

SEC source: 0001596783-19-000160 · wf-form4_156684891234566.xml · nonDerivative · entry 1

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,603

F1 · kind: Received upon the achievement of the fiscal 2017-19 performance-based vesting criteria set forth in certain incentive compensation held by the reporting person under the issuer's long-term incentive plan.

F2 · balance_after: Includes restricted stock units.

Read SEC document
July 26, 2019 Filed Jul 30, 2019 20:21 UTC Catalent, Inc. CTLT · Entity 16279 Tax withholdingCommon Stock 954 $57.26 $54,626.04
Disclosure

SEC source: 0001596783-19-000103 · wf-form4_156451807113155.xml · nonDerivative · entry 1

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,342

F1 · balance_after: Includes restricted stock units.

Read SEC document
July 22, 2019 Filed Jul 25, 2019 00:53 UTC Catalent, Inc. CTLT · Entity 16279 GrantOptions to purchase Common Stock · Derivative 15,697 $0.00 Strike: $54.94 $0.00
Disclosure

SEC source: 0001596783-19-000080 · wf-form4_156401598974235.xml · derivative · entry 2

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,697

Underlying: Common Stock · 15,697 shares

Expires 2029-07-22

F3 · shares: Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan.

F4 · derivative.exercise_date: The options vest and become exercisable in four equal annual installments beginning on July 22, 2020.

Read SEC document
July 22, 2019 Filed Jul 25, 2019 00:53 UTC Catalent, Inc. CTLT · Entity 16279 GrantCommon Stock 2,913 $0.00 $0.00
Disclosure

SEC source: 0001596783-19-000080 · wf-form4_156401598974235.xml · nonDerivative · entry 1

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,296

F1 · shares: Restricted stock units (RSUs) received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur three (3) years from the date of award.

F2 · balance_after: Includes restricted stock units.

Read SEC document
May 28, 2019 Filed May 30, 2019 22:54 UTC Catalent, Inc. CTLT · Entity 16279 Exercise / conversionOptions to purchase Common Stock · Derivative 9,453 $0.00 Strike: $10.71 $0.00
Disclosure

SEC source: 0001596783-19-000051 · wf-form4_155925684787126.xml · derivative · entry 3

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,453 shares

Expires 2019-10-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Exercised in contemplation of upcoming expiration.

Read SEC document
May 28, 2019 Filed May 30, 2019 22:54 UTC Catalent, Inc. CTLT · Entity 16279 Tax withholdingCommon Stock 4,677 $46.23 $216,217.71
Disclosure

SEC source: 0001596783-19-000051 · wf-form4_155925684787126.xml · nonDerivative · entry 2

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,383

F2 · kind: Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options.

F1 · balance_after: Includes restricted stock units.

Read SEC document
May 28, 2019 Filed May 30, 2019 22:54 UTC Catalent, Inc. CTLT · Entity 16279 Exercise / conversionCommon Stock 9,453 $10.71 $101,241.63
Disclosure

SEC source: 0001596783-19-000051 · wf-form4_155925684787126.xml · nonDerivative · entry 1

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,060

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes restricted stock units.

Read SEC document
October 15, 2018 Filed Oct 16, 2018 19:55 UTC Catalent, Inc. CTLT · Entity 16279 Tax withholdingCommon Stock 303 $41.47 $12,565.41
Disclosure

SEC source: 0001596783-18-000154 · wf-form4_153971970886381.xml · nonDerivative · entry 1

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,607

F1 · shares: Represents shares withheld to pay the applicable withholding taxes associated with the vesting of certain restricted stock units granted by the Issuer to the reporting person pursuant to the Issuer's 2014 Omnibus Incentive Plan.

F2 · balance_after: Includes restricted stock units.

Read SEC document
August 27, 2018 Filed Aug 29, 2018 20:49 UTC Catalent, Inc. CTLT · Entity 16279 Tax withholdingCommon Stock 502 $43.66 $21,917.32
Disclosure

SEC source: 0001596783-18-000118 · wf-form4_153557578299218.xml · nonDerivative · entry 1

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,914

F1 · balance_after: Includes restricted stock units.

Read SEC document
August 27, 2018 Filed Sep 4, 2018 23:51 UTC Amendment Catalent, Inc. CTLT · Entity 16279 Tax withholdingCommon Stock 502 $43.66 $21,917.32
Disclosure

SEC source: 0001596783-18-000138 · wf-form4a_153610509689856.xml · nonDerivative · entry 1

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,910

F1 · acquired: The original Form 4, filed on August 29, 2018, is being amended by this Form 4 amendment to correct a clerical error, which misreported a disposition of shares in connection with vesting-related tax withholding as an acquisition in column 4 of Table I. The reporting person's holdings in column 5 of Table I are also adjusted to reflect this correction.

F1 · balance_after: The original Form 4, filed on August 29, 2018, is being amended by this Form 4 amendment to correct a clerical error, which misreported a disposition of shares in connection with vesting-related tax withholding as an acquisition in column 4 of Table I. The reporting person's holdings in column 5 of Table I are also adjusted to reflect this correction.

F2 · balance_after: Includes restricted stock units.

Read SEC document
August 23, 2018 Filed Aug 27, 2018 21:23 UTC Catalent, Inc. CTLT · Entity 16279 Tax withholdingCommon Stock 1,835 $41.83 $76,758.05
Disclosure

SEC source: 0001596783-18-000094 · wf-form4_153540498458858.xml · nonDerivative · entry 2

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,412

F2 · balance_after: Includes restricted stock units.

Read SEC document
August 23, 2018 Filed Aug 27, 2018 21:23 UTC Catalent, Inc. CTLT · Entity 16279 GrantCommon Stock 5,349 $0.00 $0.00
Disclosure

SEC source: 0001596783-18-000094 · wf-form4_153540498458858.xml · nonDerivative · entry 1

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,247

F1 · kind: Received upon the achievement of the fiscal 2016-18 performance-based vesting criteria set forth in certain performance share units held by the reporting person.

F2 · balance_after: Includes restricted stock units.

Read SEC document
July 23, 2018 Filed Jul 25, 2018 17:46 UTC Catalent, Inc. CTLT · Entity 16279 GrantOptions to purchase Common Stock · Derivative 18,707 $0.00 Strike: $43.88 $0.00
Disclosure

SEC source: 0001596783-18-000048 · wf-form4_153254073781311.xml · derivative · entry 2

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,707

Underlying: Common Stock · 18,707 shares

Expires 2028-07-23

F3 · shares: Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan.

F4 · derivative.exercise_date: The options vest and become exercisable in four equal annual installments beginning on July 23, 2019.

Read SEC document
July 23, 2018 Filed Jul 25, 2018 17:46 UTC Catalent, Inc. CTLT · Entity 16279 GrantCommon Stock 3,647 $0.00 $0.00
Disclosure

SEC source: 0001596783-18-000048 · wf-form4_153254073781311.xml · nonDerivative · entry 1

Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,898

F1 · shares: Restricted stock received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Subject to forfeiture until vested on third anniversary of grant.

F2 · balance_after: Includes restricted stock units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.